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1. INTRODUCTION
1.1 HERBAL MEDICINE
Herbal medicine also called botanical medicine or phytomedicine refers to using a plant’s
seeds, berries, root, leaves, bark or flowers for medicinal purposes. Herbalism has a long
traditional of use outside of conventional medicine. It is becoming more main stream as
improvement in analysis and quality control along with advance in clinical research show the
value of herbal medicine in the treating and preventing disease.
Herbal Medicine is the use of whole plant preparations and is the oldest known form of
medicine. It has been used for over 2,000 years and is still the major form of medicine for
over 75% of the world’s population. Our ancestors used trial and error to discover the most
effective local plants for the treatment of illnesses. Advances in science have enabled a better
understanding of the physiological effects of herbs on the human body and therefore their
role in restoring health. Herbal medicines support the body’s natural healing process and aim
to treat the person as well as the disease. This means it can bring about a deep and lasting
change.
During the course of history the cure of disease and the use of medicinal plant have been
much influenced by religious practice and exercise of magical rites. An herbal remedy is one
in which the main therapeutic activity depends on the plant or fungal metabolites. From a
pharmacological viewpoint the study of herbal medicines differ little from that for hallopathic
medicinal plant. In practice however, many herbal medicines have not been extensively
studied either pharmacologically or phytochemically.
Herbal medicines are a major component in all indigenous people’s traditional
medicine and a common element in Ayurvedic, Homeopathic, Naturopathic, Traditional,
Oriental, and Native American Indian medicine. Many drugs commonly used today are of
herbal origin. Indeed, about 25 percent of the prescription drugs dispensed in the United
States contain at least one active ingredient derived from plant material. Some are made from
plant extracts; others are synthesized to mimic a natural plant compound. Major
pharmaceutical companies are currently conducting extensive research on plant materials
gathered from the rain forests and other places for their potential medicinal value. As a result
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of modern isolation techniques and pharmacological testing procedures, new plant drugs
usually find their road into the medicines as purified substances (Sectoral study, 1996.,
Kokate et al., 1997).
1.2 INDIAN HERBAL MARKET
India can be a major player in the global market for herb based medicines. Exports of
herbal materials and medicines can jump from just Rs. 456 crore now to Rs.10,000 crore by
2010 (Gupta and Chitme, 2000). Herbal medicines also find market as nutraceuticals (health
foods), whose current market is estimated at about $ 80-250 billion in USA and also in
Europe (Kamboj, 2000).
The criteria for the selection of plants for herbal drug research for various human
ailments are as follows:
 Actual use of the medicinal plants in the countries of the region.
 Scientific literatures indicating therapeutic efficacy of the plants in certain diseases.
 Mention of the plants in early texts as having therapeutic effects.
 Use of medicinal plants for therapeutic purposes in countries outside the region.
To evaluate plants with possible therapeutic effects, the first World Congress of
Clinical Pharmacology and Therapeutics was held in London in 1980. The traditional
approach on herbal drug research consists of the following steps.
 Identification of the plant reportedly in use.
 Collection of the plant.
 Transport of the plant to the research laboratory.
 Storage of the plant.
 Preparation of the extracts.
 Toxicity studies of the plant extracts in animals.
 Evaluation of therapeutic efficacy of the extract in animal models.
 Identification of the extracts which is having more activities.
 Further fractionation of the active molecule.
 Structural elucidation of the bio-active molecule.
 Synthesis of bio-active molecule.
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Today, phytomedicines are flooding the markets of advanced countries and the
consumer world over have shown the preference for natural herbal based formulations. With
the advent of automated high-throughput screening methods, the pharmaceutical industry in
the West has demonstrated a renewed commitment to searching for new medicinal agents
from higher plants. Solanum torvum(Telesphore et al.,2008), Toona ciliate(Malairajan et al.,
2007), Ocimum suave(paul v. et.al.,2002), Rhizopora mangle L(Berenguer et.al.,2005),
Asparagus racemosus(Sairam k et.al.,2002), Ficus glomerata(Rao, C V.et.al.,2008) are some
of the plants reported to possess gastroprotective properties, containing flavonoids,
triterpenoids, saponins and tannins and phenolic compounds as their important
phytoconstituent.
1.3 TRADITIONAL HERBAL MEDICINES AND PUBLIC HEALTH CARE
Indian traditional medicine is based on various system including ayurveda, siddha and unani.
These traditional system of Indian medicine have their uniqueness, but there is a common
fundamental principle and practices.
According to the WHO, the definition of traditional medicine may be summarized as the sum
of total of all the knowledge and practice, used in the diagnosis, prevention and elimination
of physical, mental or social imbalance and relaying exclusivisely on practical experience and
observation handed down from generation to generation, whether verbally or in writing. The
medicinal plant play a major role and constitute the backbone of the traditional medicine.
Indian material includes about 2000 drugs of natural orgin.
1.4 DIFFERENT TRADITIONAL SYSTEM AND FOLKLORE PRACTICES.
The traditional system of health care has its own particulars approach to health have
undergone a major revival in the last twenty years. Every region has its history of traditional
medicine. The medicine is traditional because it is deeply rooted in a specific socio-cultural
context, which varies from one community to another.  Each community has its own
particular approach to health and disease even at the level of ethenopathogenic perception of
disease and therapeutic behaviour.
Traditional use of herbal medicine is the basis and integral part of various culture for
thousand of years. plant based drugs(natural drug) may be used directly or they may be
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collected, dried and used as therapeutic agents(crude drug) or their chief active constituents
are separated by various chemical process which are employed as medicines.
1.5 IMPORTANCE OF HERBAL
Herbs are staging a comeback and herbal ‘renaissance’ is happening all over the globe. The
herbal products today symbolise safety in contrast to the synthetics drug that are regarded as
unsafe to human and environment. Although herbs had been priced for their medicinal,
flavouring and aromatic qualities for centuries, the synthetic products of the modern age
surpassed their importance, for a while. However, the blind dependence on synthetics is over
and people are returning to the naturals with hope of safety and security.
Our ancestors used trial and error to discover the most effective local plants for the treatment
of illnesses. Advances in science have enabled a better understanding of the physiological
effects of herbs on the human body and therefore their role in restoring health. Herbal
medicines support the body’s natural healing process, and aim to treat the person as well as
the disease. This means it can bring about a deep and lasting change.
1.6 PROSPECTS OF HERBAL RESEARCH
There is a worldwide ‘green revolution, (Mukherjee, P.K., 2002) which is reflected in the
belief that herbal remedies are safer and less damaging to the human body than synthetic
drugs. Furthermore, underlying this upsurge of interest in plants is the fact that many
important drugs in use today were derived from plants or from starting molecules of plant
origin.
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Nervous system
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Central Nervous System:-
The central nervous system is divided into two major parts: the brain and the spinal cord. The
average adult human brain weighs 1.3 to 1.4 kg. The brain contains nerve cells (neurons) and
"support cells" called glia. The spinal cord is about 43 cm long in adult women and 45 cm
long in adult men and weighs about 35-40 grams. The vertebral column, the collection of
bones (back bone) that houses the spinal cord, is about 70 cm long. Therefore, the spinal cord
is much shorter than the vertebral column.
Brain
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Saggital section
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1. Medial frontal gyrus 2.Cingulate sulcus 3. Cingulate gyrus 4.Central sulcus 5.Paracentral
lobule 6.Callosal sulcus 7.Isthmus of cingulate gyrus 8.Subparietal sulcus 9.Precuneus
10.Parieto-occipital sulcus 11.Cuneus 12.Calcarine sulcus or fissure 13.Rostrum of corpus
callosum 14.Genu of corpus callosum 15.Trunk of corpus callos 16.Splenium of corpus
callosum 17.Choroid plexus in interventricular foramen 18.Interthalamic adhesion 19.
Habenular trigone 20.Hypothalamic sulcus 21. Pineal body 22.Anterior (rostral) commissure
23.Tectum of midbrain 24.Mamillary body 25.Medial longitudinal fasciculus 26. Choroid
plexus of 4th ventricle
1. Frontal pole 2.Superior frontal sulcus 3.Middle frontal gyrus 4.Superior frontal gyrus
5.Precentral sulcus 6.Longitudinal cerebral fissure 7 Precentral gyrus 8.Postcentral gyrus 9.
Central sulcus 10.Postcentral sulcus 11. Occipital pole
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Telencephelon Diencephelon Metencephelon
Mesencephelon                  Myelencephelon
Cerebral Cortex
The word "cortex" comes from the Latin word for "bark" (of a tree). This is because the
cortex is a sheet of tissue that makes up the outer layer of the brain. The thickness of the
cerebral cortex varies from 2 to 6 mm. The right and left sides of the cerebral cortex are
connected by a thick band of nerve fibers called the "corpus callosum." In higher mammals
such as humans, the cerebral cortex looks like it has many bumps and grooves. A bump or
bulge on the cortex is called a gyrus (the plural of the word gyrus is "gyri") and a groove is
called a sulcus (the plural of the word sulcus is "sulci"). Lower mammals like rats and mice
have very few gyri and sulci.
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Functions: Thought, Voluntary movement, Language, Reasoning, Perception.
Cerebellum
The word "cerebellum" comes from the Latin word for "little brain." The cerebellum is
located behind the brain stem. In some ways, the cerebellum is a bit like the cerebral cortex:
the cerebellum is divided into hemispheres and has a cortex that surrounds these
hemispheres.
Functions: Movement, Balance, Posture.
Hypothalamus
The hypothalamus is composed of several different areas and is located at the base of the
brain. It is only the size of a pea (about 1/300 of the total brain weight), but it is responsible
for some very important behaviours. One important function of the hypothalamus is the
control of body temperature. The hypothalamus acts like a “thermostat" by sensing changes
in body temperature and then sending out signals to adjust the temperature. For example, if
you are too hot, the hypothalamus detects this and then sends out a signal to expand the
capillaries in your skin. This causes blood to be cooled faster. The hypothalamus also
controls the pituitary.
Functions: Body Temperature, Emotions, Hunger, Thirst, Circadian Rhythms.
Brain stem
The brain stem is a general term for the area of the brain between the thalamus and spinal
cord. Structures within the brain stem include the medulla, Pons, tectum, reticular formation
and tegmentum. Some of these areas are responsible for the most basic functions of life such
as breathing, heart rate and blood pressure.
Functions: Breathing, Heart Rate, Blood Pressure
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Thalamus
The thalamus receives sensory information and relays this information to the cerebral cortex.
The cerebral cortex also sends information to the thalamus which then transmits this
information to other areas of the brain and spinal cord.
Functions: Sensory Integration, Motor Integration
Limbic System
The limbic system (or the limbic areas) is a group of structures that includes the amygdala,
the hippocampus, mammillary bodies and cingulate gyrus. These areas are important for
controlling the  emotional response to a given situation. The hippocampus is also important
for memory.
Functions: Emotional Behaviour
Hippocampus
The hippocampus is one part of the limbic system that is important for memory and learning.
Functions: Learning, Memory.
Basal Ganglia
The basal ganglia are a group of structures, including the globus pallidus, caudate nucleus,
subthalamic nucleus, putamen and substantia nigra that are important in coordinating
movement.
Functions: Movement
Midbrain
The midbrain includes structures such as the superior and inferior colliculi and red nucleus.
There are several other areas also in the midbrain.
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Functions: Vision, Audition, Eye Movement, Body Movement.
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Hind brain:-
The hindbrain or brain stem consists of three parts. The first is the medulla, which is
actually an extension of the spinal cord into the skull. Besides containing tracts up and down
to and from the higher portions of the brain, the medulla also contains some of the essential
nuclei that govern respiration and heart rate. The upper part of the medulla contains a pinky-
sized complex of nuclei called the reticular formation. It is the regulatory system for sleep,
waking, and alertness.
The second part is the pons, which means bridge in Latin. The pons sits in front of the
medulla, and wraps around it to the back. It is primarily the pathways connecting the two
halves of the next part, which is called the cerebellum.
The cerebellum, which means "little brain" in Latin, is in fact shaped like a small brain, and
it is primarily responsible for coordinating involuntary movement. It is believed that, when
you learn complex motor tasks, the details are recorded in the cerebellum.
Functions:-
The Medulla Oblongata
Helps control the body's autonomic functions (things you don't need to think about to
perform) like respiration, digestion and heart rate. Also acts as a relay station for nerve
signals going to/from the brain
 The Pons
Have roles in your level of arousal or consciousness and sleep. Relays sensory information
to/from the brain. Also involved in controlling autonomic body functions.
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 The Cerebellum
Mostly deals with movement. It regulates and coordinates movement, posture and balance.
Also involved in learning movement.
Spinal cord:-
The spinal cord is a long, thin, tubular bundle of nervous tissue and support cells that
extends from the brain (the medulla oblongata specifically). The brain and spinal cord
together make up the central nervous system (CNS). The spinal cord begins at the occipital
bone and extends down to the space between the first and second lumbar vertebrae; it does
not extend the entire length of the vertebral column. It is around 45 cm (18 in) in men and
around 43 cm (17 in) long in women. Also, the spinal cord has a varying width, ranging from
1/2 inch thick in the cervical and lumbar regions to 1/4 inch thick in the thoracic area. The
enclosing bony vertebral column protects the relatively shorter spinal cord. The spinal cord
functions primarily in the transmission of neural signals between the brain and the rest of the
body but also contains neural circuits that can independently control numerous reflexes and
central pattern generators. The spinal cord has three major functions: as a conduit for motor
information, which travels down the spinal cord, as a conduit for sensory information in the
reverse direction, and finally as a center for coordinating certain reflexes.
Structure:-
The spinal cord is the main pathway for information connecting the brain and peripheral
nervous system. The length of the spinal cord is much shorter than the length of the bony
spinal column. The human spinal cord extends from the foramen magnum and continues
through to the conus medullaris near the second lumbar vertebra, terminating in a fibrous
extension known as the filum terminale.
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It is about 45 cm (18 in) long in men and around 43 cm (17 in) in women, ovoid-shaped, and
is enlarged in the cervical and lumbar regions. The cervical enlargement, located from C3 to
T2 spinal segments, is where sensory input comes from and motor output goes to the arms.
The lumbar enlargement, located between L1 and S3 spinal segments, handles sensory input
and motor output coming from and going to the legs.
The spinal cord is protected by three layers of tissue, called spinal meninges that surround the
canal. The dura mater is the outermost layer, and it forms a tough protective coating. Between
the dura mater and the surrounding bone of the vertebrae is a space called the epidural space.
The epidural space is filled with adipose tissue, and it contains a network of blood vessels.
The arachnoid mater is the middle protective layer. Its name comes from the fact that the
tissue has a spider web-like appearance. The space between the arachnoid and the
underlyng piamatter is called subarachnoid space. The subarachnoid space
contains cerebrospinal fluid (CSF). The pia mater is the innermost protective layer. It is very
delicate and it is tightly associated with the surface of the spinal cord. The cord is stabilized
within the duramater by the connecting denticulate ligaments, which extend from the
enveloping pia mater laterally between the dorsal and ventral roots. The dural sac ends at the
vertebral level of the second sacral vertebra.
In cross-section, the peripheral region of the cord contains neuronal white matter tracts
containing sensory and motor neurons. Internal to this peripheral region is the gray, butterfly-
shaped central region made up of nerve cell bodies. This central region surrounds the central
canal, which is an anatomic extension of the spaces in the brain known as the ventricles and,
like the ventricles, contains cerebrospinal fluid. The spinal cord has a shape that is
compressed dorso-ventrally, giving it an elliptical shape. The cord has grooves in the dorsal
and ventral sides. The posterior median sulcus is the groove in the dorsal side, and the
anterior median fissure is the groove in the ventral side.
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CNS Neurotransmitters:-
Type Neurotransmitter Postsynaptic effect
Acetylcholine Excitatory
Amino acids Gamma amino butyric acid GABA Inhibitory
Glycine Inhibitory
Glutamate Excitatory
Aspartate Excitatory
Biogenic amines Dopamine Excitatory
Noradrenaline Excitatory
Serotonin Excitatory
Histamine Excitatory
Neuropeptide neurotransmitters
Corticotrophin releasing hormone Somatostatin
Corticotrophin (ACTH) Bradykinin
Beta-endorphin Vasopressin
Substance P Angiotensin II
Neurotensin
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Neurotransmitter Actions
Acetylcholine Muscle activation,     learning, and memory,
arousal.
GABA Inhibition
Glutamate Excitation
Serotonin Mood, anxiety, appetite, eating behaviour, sleep
Dopamine Attention and executive functioning, motivated
behaviours (reward- and pleasure-seeking),
addictions, mood, movement, psychosis
Norepinephrine Arousal, concentration, learning and memory, mood,
stress response
Epinephrine (adrenaline) Peripheral activation and arousal, fight or flight
response
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Overview of Transmitter Pharmacology in the Central Nervous System
TRANSMITTER TRANSPORTER
BLOCKER*
RECEPTOR AGONISTS RECEPTOR-EFFECTOR
COUPLING
SELECTIVE
ANTAGONISTS
SUBTYPE MOTIF (IR/GPCR)
GABA Guvacine, nipecotic acid GABAA Muscimol IR: classical fast inhibitory
transmission
via Cl- channels
Bicbicuculline
α, β, γ, δ, σ
isoforms
Isoguvacine Picrotoxin
THIP SR 95531
(β-Alanine for glia) GABAB Baclofen IR: pre- and post-synaptic effects 2-hydroxy-s-
Saclofen
3Aminopropyl
phosphinic acid
CGP35348
CGP55845
GABAC IR: slow, sustained responses via
Cl- channels
Glycine ? Sarcosine α and β
subunits
β-Alanine; taurine IR: classical fast inhibitory
transmission via Cl- channels
(insensitive to bicuculline and
picrotoxin)
Strychnine
Glutamate — AMPA Quisqualate IR: classical fast excitatory
transmission via cation channels
NBQX
Aspartate — GLU 1-4 Kainate CNQX
AMPA GYK153655
KA Domoic acid CNQX
GLU 5-7; KA
1,2
Kainate LY294486
NMDA NMDA IR: depolarization Mg2+-gated slow
excitatory transmission
MK801
NMDA 1,2A-D GLU, ASP AP5
Ketamine, PCP
mGLU 1,5
(Group I
mGluRs)
3,5-DHPG GPCRs: modulatory; regulate ion
channels, second messenger
production, and protein
phosphorylation
In vitro coupling; Group I, Gq;
Groups II and III, Gi
mGLU 2,3
(Group II
mGluRs)
APDC
LY354740
mGLU 4,6,7,8 (Group III
mGluRs)
L-AP4
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Acetylcholine — Nicotinic IR: classical fast excitatory
transmission via cation channels
α-Bungarotoxin
α2-4 and β2-4
isoforms
Me-Lycaconitine
α 7
Muscarinic GPCR: modulatory M1: Pirenzepine
M1-4 M1, M3: Gq, ↑IP3/Ca2+ M2: Methoctramine
M2, M4: Gi, ↓cAMP M3: Hexahydrosiladi-
fenidol
M4: Tropicamide
Dopamine Cocaine; mazindol; GBR12-
395; nomifensine
D1-5 D1: SKF38393 GPCR: D1 D5: Gs coupled; D2,3,4: Gi coupled D1: SCH23390
D2: Bromocriptine D2: Sulpiride,
domperidone
D3: 7-OH-DPAT
Norepinephrine Desmethylimipramine;
mazindol, cocaine
α1A-D α1A: NE > EPI GCPR: G q/11 coupled WB4101
α2A-C α2A: Oxymetazoline GCPR: G i/o coupled α2A-C: Yohimbine
α2B, α2C: Prazosin
β1-3 β1: EPI = NE GPCR: Gs coupled β1: Atenolol
β2: EPI >> NE β2: Butoxamine
β3: NE > EPI GPCR: Gs/G i/o coupled β3: BRL 37344
Serotonin Clomipramine; sertraline;
fluoxetine
5-HT1A-F 5-HT1A: 8-OH-DPAT GPCR: Gi/o coupled 5-HT1A: WAY101135
5-HT1B: CP93129 5-HT1D GR127935
5-HT1D: LY694247
5-HT2A-C α-Me-5-HT, DOB GPCR: Gq/11 coupled LY53857; ritanserin;
mesulergine; ketanserin
5-HT3 2-Me-5-HT; m-CPG IR: classical fast excitatory transmission via
cation channels
Tropisteron: ondansetron;
granisetron
5-HT4-7 5-HT4: BIMU8; RS67506;
renzapride
GPCR: 5-HT4,6,7, Gs coupled 5-HT5, Gs
coupled?
5-HT4: GR113808;
SB204070
Histamine — H1 2-Pyridylethylamine GPCR: Gq/11 coupled Mepyramine
2-Me-histamine
H2 Methylhistamine; dimaprit,
impromadine
GPCR: Gs coupled Ranitidine, famotidine,
cimetidine
H3 H3: R-α-Me-histamine GPCR: Gi/o? H3: Thioperamide
Autoreceptor function: inhibits transmitter
release
H4 Imetit, clobenpropit GPCR: Gq, Gi? JNJ777120
Vasopressin — V1A,B — GPCR: Gq/11 coupled; modulatory; regulates
ion channels, second messenger production,
and protein phosphorylation
V1A: SR 49059
V2 DDAVP GPCR: Gs coupled d(CH2)5[dIle2Ile4]AVP
Oxytocin — [Thr4,Gly7]OT GPCR: Gq/11 coupled d(CH2)5[Tyr(Me)2, Thr4,
Orn8]OT1-8
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Tachykinins — NK1 (SP > NKA >
NKB)
Substance P Me ester GPCR: Gq/11 coupled; modulatory; regulates
ion channels, second messenger production,
and protein phosphorylation
SR140333
LY303870
CP99994
NK2 (NKA > NKB > SP) β-[Ala8]NKA4-10 GR94800
GR159897
NK3 (NKB >
NKA > SP)
GR138676 SR142802
SR223412
[Pro7]NKB
CCK — CCKA CCK8 >> gastrin 5 = CCK4 GPCR: Gq/11 and Gs coupled Devazepide; lorglumide
CCKB CCK8 > gastrin 5 = CCK4 GPCR: Gq/11 coupled CI988; L365260; YM022
NPY — Y1 [Pro34]NPY GPCR: Gi/o coupled —
Y2 NPY13-36; NPY18-36
Y4-6 NPY13-36; NPY18-36
Neurotensin — NTS1 — GPCR: Gq/11 coupled SR48692
NTS2
Opioid peptides — u (β-endorphin) DAMGO, sufentanil; DALDA GPCR: Gi/o coupled CTAP; CTOP; β-FNA
δ (Met5-Enk) DPDPE; DSBULET; SNC-80 Naltrindole; DALCE;
ICI174864; SB205588
κ (Dyn A) U69593; CI977; ICI74864 Nor-binaltorphimine;
7-[3-(1-piperidinyl)
propanamido] morphan
Somatostatin — sst1A-C SRIF1A; seglitide GPCR: Gi/o coupled —
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sst2A,B Octreotide; seglitide,
BIM23027
Cyanamid 154806
sst3,4 BIM23052, NNC269100
sst5 L362855 BIM23056
Purines — P1 (A1,2a,2b,3) A1: N6-cyclopentyladenosine GPCR: Gi/o coupled 8-Cyclopentyl
theophylline; DPCPX
A2a: CGS21680; APEC;
HENECA
GPCR: Gs coupled CO66713; SCH58261;
ZM241385
P2X α,β-methylene ATP IR: transductive effects not yet determined Suramin (nonselective)
P2Y ADP β F GPCR: Gi/o and Gq/11 coupled Suramin
CNS Depression:-
The causes of depression are not entirely understood, but are thought to be multi-factorial.
Studies indicate that depression is, at least in part, an inherited condition involving
abnormalities in neurotransmitter functioning. Although inheritance is an important factor in
major depression, it does not account for all cases of depression, implying that environmental
factors may either play an important causal role or exacerbate underlying genetic
vulnerabilities. Some of the common causes of depression which have been identified include
the following:
1. Genetics:-Research indicates that depression is, at least in part, inherited. Thus far,
however, no studies have isolated the specific genes responsible for depression.
2. Brain Chemistry Imbalance: - Depression is believed to be caused by an imbalance in
the neurotransmitters which are involved in mood regulation. Neurotransmitters are chemical
substances which help different areas of the brain communicate with each other. When
certain neurotransmitters are in short supply, this may lead to the symptoms we recognize as
clinical depression.
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3. Circadian Rhythm Disturbance: - One type of depression, called seasonal affective
disorder, is believed to be caused a disturbance in the normal circadian rhythm of the body.
Light entering the eye influences this rhythm, and, during the shorter days of winter, when
people may spend limited time outdoors, this rhythm may become disrupted.
4. Poor Nutrition: - A poor diet can contribute to depression in several ways. A variety of
vitamin and mineral deficiencies are known to cause symptoms of depression. Researchers
have also found that diets either low in omega-3 fatty acids or with an imbalanced ratio of
omega-6 to omega-3 are associated with increased rates of depression. In addition, diets high
in sugar have been associated with depression.
5. Medical Illnesses: - Illness is related to depression in two ways. The stress of having a
chronic illness may trigger an episode of major depression. In addition, certain illnesses -- for
example, thyroid disorders, Addison's disease and liver disease -- can cause depression
symptoms.
6. Drugs, Both Legal and Illegal: - Several prescription drugs have been reported to cause
symptoms of depression. In addition, a variety of drugs of abuse have been associated with
depression symptoms.
7. Female Sex Hormones: - It has been widely documented that women suffer from major
depression about twice as often as men. Because the incidence of depressive disorders peaks
during women's reproductive years, it is believed that hormonal risk factors may be to blame.
Women are especially prone to depressive disorders during times when their hormones are in
flux, such as around the time of their menstrual period, childbirth and perimenopause. In
addition, a woman's depression risk declines after she goes through menopause.
8. Grief and Loss: - Although grief is a normal response to death and loss, the extreme stress
associated with grief can trigger an episode of major depression.
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9. Stressful Life Events: - Stressful life events, which overwhelm a person's ability to cope,
may be a cause of depression. Scientists have theorized that the high levels of the hormone
cortisol, which are secreted during periods of stress, may somehow induce depression by
affecting the neurotransmitter serotonin.
Depression due to neurotransmitters:-
Depression is believed to occur when there are imbalances in the
brain of mood-regulating chemicals called neurotransmitters. Neurotransmitters are chemical
messengers that help nerve cells communicate with each other when they are in short supply,
problems may occur. There are three basic molecules, known chemically as monoamines,
which are thought to play a role in mood regulation: norepinephrine, serotonin and
dopamine.
Motivation, psychomotor speed, concentration, and the ability to experience pleasure are all
linked in that (1) they are regulated in part by dopamine containing circuits in the central
nervous system and (2) impairment of these functions are prominent features of depression.
Despite this theoretical underpinning, research on the role of dopamine in depression has
been largely overshadowed by research on norepinephrine and serotonin containing circuits.
Recent findings clearly warrant scrutiny of the role of dopamine in the pathophysiology of
depression and, moreover, whether there exists a “dopaminergic dysfunction” subtype,
characterized by a poor response to antidepressants that act primarily on serotonin or
noradrenaline neurons.
Role of Dopamine in CNS depression:- The dopamine is the important neurotransmitter that
plays a major in depression, psychosis, anxiety, addictions, mood, movement, attention and executive
functioning, motivated behaviours (reward- and pleasure-seeking).
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DOPAMINE SYNTHESIS & SIGNALING:-
Dopamine is synthesized in the cytoplasm of presynaptic neurons from the amino acids
phenylalanine and tyrosine. Dopamine is biosynthesized in the body (mainly by nervous
tissue and the medulla of the adrenal glands) first by the hydroxylation of the amino acid L-
tyrosine to L-DOPA via the enzyme tyrosine 3-monooxygenase, also known as tyrosine
hydroxylase, and then by the decarboxylation of L-DOPA by aromatic L-amino acid
decarboxylase (which is often referred to as dopa decarboxylase). In some neurons, dopamine
is further processed into norepinephrine by dopamine beta-hydroxylase.
In neurons, dopamine is packaged after synthesis into vesicles, which are then released into
the synapse in response to a presynaptic action potential.
Dopaminergic synaptic signaling. Szabo et al (2004).5 AADC indicates aromatic acid decarboxylase; AMPT,-
methylparatyrosine; AC, adenylyl cyclase; cAMP, cyclic adenosine monophosphate; COMT, catechol-O-methyltransferase;
D1-D5, dopamine receptors 1 through 5; DA, dopamine; DAT, dopamine transporter; DOPA, 3,4-dihydroxyphenylalanine;
DOPAC, dihydroxyphenylacetic acid; Gi, Go, and Gs, protein subunits; HVA, homovanillic acid; MAO, monoamine
oxidase; MT, 3 methoxytyramine; TH, tyrosine hydroxylase; and VMAT, vesicular monoamine transporter.
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Dopamine exerts its effects on the postsynaptic neuron through its interaction with 1 of 5
subtypes of dopamine receptors, divided into 2 groups:-
D1 family comprising the D1 and D5 subtypes receptors &
D2 family comprising the D2, D3, and D4 subtypes receptors.
The structure of all of the receptor subtypes conforms to the structural model for a G-protein
coupled receptor with 7 membrane-spanning alpha-helices and an extracellular amino
terminal. Each receptor subtype has a characteristic anatomical distribution with the D1 and
D2 subtypes present in significantly greater amounts than the others. On binding an agonist,
D1 and D5 receptors activate the adenylate cyclase second messenger system, elevating
intracellular cyclic adenosine monophosphate concentrations. Cyclic adenosine
monophosphate increases protein kinase A activity with resulting changes in activity levels of
enzymes or other proteins within the cell.
D1 receptors may also activate other second messenger pathways, perhaps
contributing to intracellular cross-talk between D1 and D2 receptors.13 The D2 family of
receptors, when stimulated, all reduce adenylate cyclise activity. Somatodendritic and
presynaptic D2 receptors also function as autoreceptors with activation of somatodendriticD2
receptors resulting in reduced DA cell firing and activation of presynaptic D2 receptors
reducing the amount of DA released per action potential.
In the basal ganglia, DA is cleared from the extracellular
space primarily by presynaptic nerve terminal uptake mediated by the dopamine transporter
(DAT). The prefrontal cortex in man and nonhuman primates represents something of an
anomaly in that there is an absence of DAT on DA nerve terminals. Consequently, the DA
signal is terminated by DA uptake into NE terminals by the norepinephrine transporter
(NET). Postsynaptically, dopamine is inactivated by catechol-o-methyl transferase (COMT).
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Both the A and B forms of monoamine oxidase (MAO-A and MAO-B) can metabolize DA,
which, along with COMT, serially catabolises DA to produce the intermediate breakdown
products dihydrophenylacetic acid and 3-methoxytyramine before forming the final excretion
product, homovanillic acid (HVA).
Dopamine signaling occurs in 2 forms. Phasic DA release results
from burst firing of VTA neurons and is thought to occur in response to behaviourally salient
stimuli, such as those that may predict reward. This phasic DA release activates postsynaptic
D2 receptors and is terminated via reuptake by DAT. Tonic dopamine release arises from
slow, irregular activity of the VTA, resulting in low concentrations of extracellular DA that
act at presynaptic DA receptors to inhibit phasic DA neuron firing, and is subject to
metabolism by COMT. There is considerable evidence that the DA system is dynamic, with
up- and down-regulation of D2 receptors and DAT based in part on DA availability.
Reserpine, which depletes DA, induces a significant decrease in DAT density and reduces
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DA uptake. Similarly, amantadine, which in part acts to induce DA release, increases DAT
density.
D1 receptor density appears to be less responsive to changes in DA
availability. Although beyond the scope of this review, it should be noted that there is
substantial evidence that DA signaling in the dorsal and ventral striatum serves in a gating
capacity for glutamatergic inputs from the hippocampus, basolateral amygdala, thalamus, and
prefrontal cortex. Dopamine performs a similar gating function over the ability of the
prefrontal cortex to regulate basolateral amygdala output.
DOPAMINERGIC PATHWAYS IN THE CENTRAL NERVOUS SYSTEM
Most DA-producing neurons in the brain are located in brainstem
nuclei: the retro-rubro field (A8), substantia nigra pars compacta (A9), and the ventral
tegmental area (VTA) (A10). Projection pathways of the axons arising from these cell bodies
follow 1 of 3 specific paths (with some overlap) via the medial forebrain bundle to innervate
specific cortical and subcortical structures, unlike the more diffuse innervation patterns of
serotonergic and noradrenergic cells. The nigrostriatal pathway projects from the substantia
nigra pars compacta to the dorsal striatum (caudate and putamen) and has a prominent role in
the motor planning and execution of movement, although it clearly also plays an important
role in non motor functions, such as cognition.
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The mesocortical pathway arises from the VTA and projects to the
frontal and temporal cortices, particularly the anterior cingulate, entorhinal, and prefrontal
cortices. This pathway is believed to be important for concentration and executive functions
such as working memory.
The mesolimbic pathway also arises in the VTA but projects to the
ventral striatum (including the nucleus accumbens), bed nucleus of the stria terminalis,
hippocampus, amygdala, and septum. It is particularly important for motivation, the
experience of pleasure, and reward. Aspects of anterior pituitary function are also under
dopaminergic control.
The tuberoinfundibular pathway arises from the arcuate nucleus of the
hypothalamus (A12) and projects to the median eminence of the hypothalamus, where DA
released into the portal vessels acts to inhibit the secretion of prolactin from the anterior
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pituitary.  This pathway is also involved in dopaminergic regulation of growth hormone
release from the anterior pituitary.
The incertohypothalamic pathway originates from cell bodies in the
medial portion of the zona incerta (A13) and innervates amygdaloid and hypothalamic nuclei
involved in sexual behavior. Recently, significant dopaminergic innervation of the thalamus
has been demonstrated in primates, although it is largely absent in rodents. Unlike the other
dopaminergic pathways, this “thalamic dopamine system” arises from multiple sites,
including the periaqueductal gray matter, the ventral mesencephalon, hypothalamic nuclei,
and the lateral parabrachial nucleus. This DA pathway may contribute to the gating of
information transferred through the thalamus to the neocortex, striatum, and amygdala.
Dysfunction of dopaminergic system & major role in depression:-
The fluctuations in the functions of dopaminergic system can play a major
role in altering the depression, psychosis, anxiety, addictions, mood, movement, attention and
executive functioning, motivated behaviours (reward- and pleasure-seeking).
Research information on role of dopamine in depression:-
Dopamine neurons have long been known to be critical to a wide variety
of pleasurable experiences and reward. Severity of major depressive disorder has been found
to correlate highly with the magnitude of reward experienced after oral d-amphetamine,
which increases DA availability by a variety of mechanisms. One explanation for these
findings is that in severe depression, there is a reduction in DA release, resulting in
compensatory mechanisms, such as up-regulation of postsynaptic DA receptors and
decreased DAT density, which taken together would increase DA signal transduction
resulting from amphetamine- induced DA release into the synapse. The markedly greater
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behavioural response to the rewarding effects of the psychostimulant and altered brain
activation of the ventrolateral prefrontal cortex, orbitofrontal cortex, caudate, and putamen.
These findings further implicate DA circuit dysfunction in major depression.
Relatively few studies have examined DA system alterations in
depression with neuroimaging methods. Published studies have focused largely onD2
receptor or DAT occupancy. Interpreting results of earlier studies using 2βcarboxymethoxy-
3β-(4-iodophenyl)tropane(123I-β-CIT) to image the DAT are problematic in that the binding
profile for this ligand is not specific for this monoamine transporter, although in the striatum,
the vast majority of binding is indeed to the DAT. Few studies of DAT binding or uptake
have been performed with more specific ligands. Results of neuroimaging studies of D2
receptor binding in major depressive disorder have been inconsistent. Lots of research to be
performed in present and future to know the complete role of dopamine in depression.
SCREENING OF CNS DEPRESSION ACTIVITY:-
 SCREENING MODELS OF ANTIPSYCHOTIC DRUGS:-
1. Catalepsy test in rodents
2. Pole climbing avoidance in rats
3. Foot shock induced aggression
4. Inhibition of amphetamine stereotype in rats
5. Inhibition of amphetamine climbing in rats
6. Inhibition of apomorphine stereotype in rats
7. Yawing and penile erection syndrome in rats
8. Active avoidance test
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8.1 Shuttle box avoidance (two way shuttle box) test
8.2 Jumping avoidance (one way shuttle box) test
8.3 Runway avoidance test
8.4 Jumping avoidance test
9. Passive avoidance test
9.1 Step down test
9.2 Step through test
9.3 Up hill avoidance tet
9.4 Two compartment test
9.5 Scopolamine induced amnesia test
10. Conditional avoidance response test in rats
 SCREENING MODELS OF ANXIOLYTIC DRUGS:-
1. Light dark model (anti anxiety test)
2. Elevated plus maze test
3. Water maze test
4. Y maze test
5. Staircase test
6. Forced swimming test
7. Open field test
8. Isolation induced aggression
9. Hole board test
10. Resident intruder aggression test
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11. Foot shock induced aggression
12. Isolation induced aggression
13. Water competition test
 SCREENING MODELS OF MYORELAXANT DRUGS:-
1. Traction test
2. Rotarod test
3. Chimney test
4. Grip strength
5. Inclined plane test
 SCREENING MODELS OF SEDATIVE DRUGS:-
1. Potentiation of hexobarbital sleeping time
2. Potentiation of Pentobarbitone sleeping time
3. Experimental insomnia in rats
4. EEG registration of conscious rat
5. Automated rat sleep analysis system
Drug profile:-
Haloperidol:- It is a typical antipsychotic drug in butyrophenone class of antipsychotic
drugs.
MOA: - Haloperidol is first-generation Neuroleptics that bind non selectively to a broad
range of receptors. It can bind to dopamine D1 and D2, 5-HT2, histamine H1 and α2
adrenergic receptors in the brain. The efficacy of neuroleptics is thought to be due to
antagonism of dopamine receptors in the mesolimbic and mesofrontal systems. Haloperidol
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blocks postsynaptic dopamine D1 and D2 receptors in the mesolimbic system. It produces
calmness and reduces aggressiveness with disappearance of hallucinations and delusions.
Diazepam:- It belongs to benzodiazepam class commonly used for for
treating anxiety, insomnia, seizures including status epilepticus, muscle spasms, restless legs
syndrome, alcohol withdrawal, benzodiazepine withdrawal and Ménière's disease.
MOA: - it binds to a specific subunit on the GABAA receptor at a site that is distinct from the
binding site of the endogenous GABA molecule. The GABAA receptor is an inhibitory
channel which, when activated, decreases neuronal activity.
Pentobarbitone: - It is a short-acting barbiturate commonly used as hypnotic & sedative
drug.
MOA: - GABA is the principal inhibitory neurotransmitter in the mammalian central nervous
system (CNS). Barbiturates bind to the GABAA receptor at the alpha subunit, which are
binding sites distinct from GABA itself and also distinct from the benzodiazepine binding
site. In addition to this GABA-ergic effect, barbiturates also block the AMPA receptor, a
subtype of glutamate receptor. Glutamate is the principal excitatory neurotransmitter in the
mammalian CNS. Taken together, the findings that barbiturates potentiate inhibitory
GABAA receptors and inhibit excitatory AMPA receptors can explain the CNS-depressant
effects of these agents.
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2. LITERATURE REVIEW
4.1 DESCRIPTION OF THE PLANT:-
Fig.5.1. Plant image of Canavalia maritima (Abul.)
 Botanical information:
Canavalia maritima (Aubl.)
Family : Fabaceae
Synonyms : Canavalia lineate auct
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Canavalia. rosea (SW.)DC. - Baybean
Canavalia obtusifolia DC.
Canavalia thours.
Vernacular Names
English :           Seaside sword bean, beach bean
Tamil : Kaathuthambattan
Taxonomical classification
Kingdom : Plantae – Plants
Subkingdom : Tracheobionta – Vascular plants
Super division : Spermatophyta – seed plants
Division : Magnoliophyta – Flowering plants
Class : Magnoliopsida - Dicotyledons
Subclass : Rosidae
Order : Fabales
Family : Fabaceae– Pea family
Genus : Canavalia adans.- jackbean
Species : Canavalia maritima
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Description:
Coastal Jack-bean is a trailing, herbaceous vine that forms mats of foliage. Stems
reach a length of more than 6 m (20 ft) and 2.5 cm (0.98 in) in thickness. Each compound
leaf is made up of three leaflets 5.1–7.6 cm (2.0–3.0 in) in diameter, which will fold
when exposed to hot sunlight. The flowers are purplish pink and 5.1 cm (2.0 in) long. The
flat pods are 10.2–15.2 cm (4.0–6.0 in) long and become prominently ridged as they
mature. The buoyancy of the seeds allows them to be distributed by ocean currents. The
plant seems to contain L-Betonicine.
Habitat:
C. maritima inhabits upper beaches, cliffs, and dunes throughout the world's coastal
tropics. It is highly salt-tolerated and prefers sandy soils.
Propagation: By seeds
Parts used : Leaves and beans
Chemical constituents:
Catalase, amylase, invertase, lipase, tannase and glucosidase. Canarosine a guanidine
alkaloid.  β–sitosterol, stigmasterol, daucosterol, epi-inositol 6-o methyl ether and rutin.
L-betonicine, canavanine, trigonelline are the active principle. It also contain glycoside
moiety like saponin, flavonoids.
\
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Uses
This is a good pioneer plant for coastal revegetation used as folkloric, paste of leaves
used for boils. It is mild psychoactive when smoked. It is used in tobacco smoking. Plant
decoction is used to treat tuberculosis. The fresh and dried flowers were used as a garnish
and for flavoring. Leaf powder is smoked as substitute for marijuana. The leaves help to
relieve pain and promote healing of burns. Powdered leaves are used for cuts, wounds,
ulcers, and swellings. An infusion of the Root is good for cold, rheumatism, leprosy,
aches and pain.
4.2 Collection of Plant:-
Plant was collected from Chudaloor seashore, Tamilnadu and authenticated by
Dr.G.V.S Murthy Scientist & Head of office, Botanical Survey of India, Coimbatore,
Tamilnadu. The fresh leaves of the plant were separated from adulterants, shade dried,
broken into small pieces and powdered coarsely.
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SCIENTIFIC REVIEW:-
Senthil kumar et al.,(2010) Has evaluated the antibacterial activity and preliminary
phytochemical analysis of leaf extract of Canavalia rosea using nine solvents. The
preliminary phytochemical screening revealed the presence of tannins, phlobatannins,
saponin, flavonoids, alkaloid, cardiac glycoside and phenolics. Presence of bioactive
constituents is associated with the anti microbial activity of the plant. Minimum
inhibition concentration and maximum bactericidal concentration on selective organisms
that were found susceptible in agar diffusion assay.
Rutt Suttisri et al., (2008) A new acyclic guanidine alkaloid, canarosine (1), together
with five known compounds, b-sitosterol (2), stigmasterol (3), daucosterol (4), epi-
inositol 6-O-methyl ether (5), and rutin (6), were isolated from the aerial parts of
Canavalia rosea. Their structures were established on the basis of their spectroscopic
data. In the radioligand receptor binding assay, canarosine (1), at a concentration of
100mg/ml, caused 91% inhibition of the dopamine D1 receptor binding with an IC50
value of 39.4 ^ 5.8mM.
Jain BG et al., (2010). Evaluated the effect of aqueous ethanolic extract of Tinospora
Cordifolia for its putative antipsychotic activity using amphetamine challenged mice
model. Haloperidol (1 mg/kg i.p.) was administered acutely to mice as standard drug.
Control animals received vehicle (10% DMSO). The in vivo receptor binding studies
were carried out to correlate the antipsychotic activity of the extract with its capacity to
bind to the DAD2 receptor. The results in SLA showed that the hydro alcoholic extract of
the stems of Tinospora cordifolia at a dose level of 250 mg/kg and 500 mg/kg showed no
significant antipsychotic activity in amphetamine induced hyperactivity in mice when
compared to standard. Extract alone treated group at a dos level of 250 mg/kg and 500
mg/kg showed a decreased in locomotor activity when compared to the control. The plant
extract increased the DAD2 receptor binding in a dose dependent manner in treated mice
compared to the control group.
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Rajesh J Oswal et al.,(2011) determined the antipsychotic ethanolic extract of activity
of dried fruits of Catunargaom spinosa (Thumb.) in rats by Compulsive behavior test.
Where Amphetamine is used to produce psychosis and Haloperidol is used as standard
drug to block psychosis and decrease dopamine levels. The ethanolic extract of Fruits of
Catunargaom spinosa (Thunb.) 400mg/kg protected some of the animals against the
psychosis induced by amphetamine and lowers the rate of Sniffing, Licking, and Rearing.
The result showed that ethanol extract of Catunargaom spinosa (Thunb), possess
antipsychotic activity in mice in over secretion of dopamine in Mesolimbic pathway
causes psychosis to occur after administration of Amphetamine.
C.A.Suresh kumar, et al., (2010) has investigated the Psychopharmacological studies on
different extracts (ethanolic, chloroform & aqueous) of stem of Saccharum spontaneum
on antipsychotic and spontaneous locomotor activity. The locomotor activity of normal
rat animal shows the C.N.S. depressant activity (6.53%). The ethanol extract shows the
10 times (62.0%) more activity while other extracts like Aqueous extract (21.9%) shows
the 4 times more activity and chloroform extract shows the 2 times (10.0%) more C.N.S.
depressant activity than the control. The aqueous & ethanolic extract of Saccharum
spontaneum delays the latency to climb the pole to (5±0.96), (4±0.76) which compared to
the control groups of rats (3±0.57). The above extracts show the antipsychotic activity
but are less when compared with standard drug of chlorpromazine. The overall results
show that Ethanol and Aqueous extract of Saccharum spontaneum must have a
significant C.N.S. depressant activity than chloroform and aqueous extracts when
compared to control.
J. Srikanth et al., studied the CNS Activity of the Methanol Extracts of Sapindus
emarginatus Vahl in Experimental Animal Models. The metholic extract at 50mg/kg,
100mg/kg, 200mg/kg influenced the general behavioral profiles, as evidenced in the
spontaneous activity, righting reflex, pinna reflex, grip strength and pain responses.
Reduction of awareness and depressant action may be due to the action of the extract on
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CNS. Reduction of pinna reflex may be due to blocking synapses of the afferent pathway.
Different doses of methanol extract of S. emarginatus have produced a significant
increase in the hypnotic effect induced by the Phenobarbitone, in a dose dependent
manner, thus suggesting a profile sedative activity. The myorelaxant effect was observed
only with the higher dose of methanol extract of S. emarginatus which resulted in an
increase in the number of falls and a decrease in the time on the bar as detected by the
rotarod test. The extract showed significant reduction in exploratory behavior in Y maze
test & Head dip test showing its anxiolytic activity. The antipsychotic activity is
evaluated by cocaine induced stereotype behavior in rats. Administration of cocaine to
rats, which releases both dopamine and noradrenalin, causes a cessation of normal 'ratty'
behavior and the appearance of repeated 'stereotyped' behavior unrelated to external
stimuli. These effects are prevented by dopamine antagonists and by destruction of
dopamine-containing cell bodies in the midbrain, but not by drugs that inhibit the
noradrenergic system. The methanol extracts of S. emarginatus produced a partial
reduction in the hyperactivity produced by cocaine. A number of scientific reports
indicated that triterpenoids produced CNS depressant action. Therefore the presence of
these active constituents in the methanol extract of S. emarginatus may be responsible for
the CNS activity.
K. Umasankar et al., (2010) evaluated the CNS Activity of Ethanol Extract of Wedelia
chinensis in Experimental Animals. The CNS effects were evaluated by general
behaviour, exploratory behaviour, muscle relaxant activity and Phenobarbitone sodium–
induced sleeping time using standard procedures in experimental animal models. The
Phytochemical screening revealed the presence of tannins, terpenoids, flavonoids,
steroids and reducing sugars. The results revealed that the ethanol extract at 200 and 300
mg/kg caused a significant reduction in the spontaneous activity (general behavioural
profile), exploratory behavioural pattern (Y–maze and head dip test), muscle relaxant
activity (rotarod and traction tests), and significantly potentiated Phenobarbitone sodium–
induced sleeping time. The results conclude that the extract exhibit CNS depressant
activity in tested animal models.
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Ramanathan Sambath Kumar, et al., (2008) investigated CNS activity of the
methanol extracts of Careya arborea in experimental animal model. General behaviour,
exploratory behaviour, muscle relaxant activity and Phenobarbitone sodium–induced
sleeping time were studied. The results revealed that the methanol extract of barks of
Careya arborea at 100 and 200 mg/kg caused a significant reduction in the spontaneous
activity (general behavioural profile), remarkable decrease in exploratory behavioural
pattern (Y–maze and head dip test), a reduction in muscle relaxant activity (rotarod and
traction tests), and also significantly potentiated Phenobarbitone sodium–induced
sleeping time. The results suggest that methanol extract of Careya arborea exhibit CNS
depressant activity in tested animal models.
Salahdeen H.M et al., (2006) evaluated the Neuropharmacological Effects of Aqueous
Leaf Extract of Bryophyllum Pinnatum in Mice. Effects of aqueous leaf extracts of
bryophyllum pinnatum (AEBP) dosages (50,100 and 200 mg/kg) was found to produce a
profound decrease in exploratory activity in a dose-dependent manner. It also showed a
marked sedative effect as evidenced by a significant reduction in gross behaviour and
potentiation of pentobarbitone-induced sleeping time. It delayed onset in strychnine-and
picrotoxin-induced convulsion (seizures) respectively with the protective effect being
significantly higher in picrotoxin- than strychnine-induced convulsion. It also decreases
the rate of picrotoxin-induced mortality in mice with LD50 of 641mg/kg. The totality of
these effects showed that the extract possesses depressant action on the central nervous
system.
Abiodun O. Ayoka et al., (2005) evaluated the effects of air-dried Spondias mombin
leaves extracted with aqueous, methanol and ethanol solvents on Sedative, antiepileptic
and antipsychotic effects in mice and rats. . All residues from different extractions were
dissolved in normal saline and administered intraperitoneally (i.p.). The methanolic and
ethanolic extracts (12.5–100 mg/kg i.p.) prolonged the hexobarbital-induced sleeping
time and reduced the NIR in both mice and rat in a dose-dependent manner. The aqueous
extract prolonged the hexobarbital-induced sleeping time and reduced (NIR) at doses of
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50 and 100 mg/kg. Phenolic compounds were present in the ethanolic and methanolic
extracts, which exhibited anticonvulsant properties in the picrotoxin-induced convulsions
model. The extracts decreased the amphetamine/apomorphine-induced stereotyped
behavior, which suggest that these extracts possess antidopaminergic activity. These
results suggest that the leaves extracts of Spondias mombin possess sedative and
antidopaminergic effects.
Sanjita Das, D et al., (2008) evaluated the CNS Depressant Activity of Different Plant
parts of Nyctanthes arbortristis Linn. The CNS depressant activity was evaluated by
observing the prolongation of sleeping time induced by pentobarbital sodium in mice and
to explore the possible mechanism behind this activity by determining their effect on
brain monoamine neurotransmitters like dopamine and serotonin. The leaves, flowers,
seeds and barks (600 mg/kg) showed significant and dose-dependent prolongation of
onset and duration of sleep and so found to cause decrease dopamine and increase
serotonin level. These results concluded that the CNS depressant activity of the ethanol
extracts of seeds, leaves and flowers may be due to the decrease in dopamine and
increase in serotonin level.
VJ Galani and BG Patel (2009) studied the Central Nervous System Activity of
Argyreia Speciosa Roots in Mice. They studied the action of the n-hexane (n-HF),
chloroform (CF), ethyl acetate (EAF) and water (WF) fractions of hydroalcoholic extract
of roots of Argyreia speciosa on the central nervous system. All the fractions (100, 200
and 500 mg/kg, p.o.) were evaluated for neuropharmacological activity using
spontaneous motor activity and pentobarbital-induced sleeping time in mice.
Chlorpromazine was used as a positive control. Central nervous system depressant
activity was observed with all the fractions as indicated by the results in which they
reduced spontaneous motor activity and potentiated pentobarbital induced hypnosis in
mice. These results suggest that the active principles present in the root of Argyreia
speciosa may responsible for central nervous depressant activity.
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Silvia R.Etcheverry et al., (2003) conducted the pharmacological studies and
Phytochemical screening of Erythrina crista-galli extracts. The aqueous and organic
extracts of the leaves were tested by the Hippocratic Screening test, Spontaneous
Locomotor activity, potentiation of pentobarbitone sleeping time test. Two extract in all
the tests showed a significant CNS depression.
SINGH, G. K. AND KUMAR, V. has evaluated the Neuropharmacological Screening &
Lack of Antidepressant activity of Standardized extract of Fumaria indica
withstandardized 50% ethanolic extract of Fumaria indica (FI) containing 0.45% fumaric
acid and 0.35% dimethyl fumarate w/w, was used in this study. Five groups of rats and
mice of either sex, each group comprising of six animals, were used (i.e. control,
respective standard drug, and 100 mg/kg, 200 mg/kg and 400 mg/kg doses of FI, p.o.).
Potentiation of pentobarbital induced sleeping time, locomotor activity, effect on muscle
grip performance of mice, maximal electroshock seizures (MES) in rats and
pentylenetetrazole (PTZ) induced convulsions in mice were used as behavioural models
to evaluate general effects of the FI on central nervous system. Further, antidepressant
activity of the extract was also evaluated using validated models of depression in rodents
viz. behavioural despair test, learned helplessness test, tail suspension test, reserpine
induced hypothermia, 5-Hydroxytryptophan (5-HTP) induced head twitches in mice and
L-dopa induced hyperactivity and aggressive behaviour in mice. The animals treated
with FI showed significant and dose dependent increase in pentobarbital-induced sleeping
time and marked decrease in onset of sleeping time in rats. FI and diazepam have shown
significant decrease in locomotor activity. FI did not show any muscle relaxant effect in
the rota-rod test in mice while diazepam has shown significant muscle relaxant effect.
FI, phenobarbitone and diazepam showed significant anticonvulsant activity in MES in
rats and PTZ induced convulsions in mice respectively. However, no antidepressant
activity was observed with FI in any of above six validatedmodels of depression. It may
be concluded that FI has significant central nervous system depressant activity and
lacking antidepressant activity in rodents.
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Maribel Herrera-Ruiz et al., (2006) worked on Antidepressant and anxiolytic effects of
hydroalcoholic extract from Salvia elegans In this work, the antidepressant and anxiolytic
like effects of hydroalcoholic (60%) extract of Salvia elegans (leaves and flowers) were
evaluated in mice. The extract, administered orally, was able to increase the percentage of
time spent and the percentage of arm entries in the open arms of the elevated plus-maze,
as well as to increase the time spent by mice in the illuminated side of the light–dark test,
and to decrease the immobility time of mice subjected to the forced swimming test. The
same extract was not able to modify the spontaneous locomotor activity measured in the
open field test. These results provide support for the potential antidepressant and
anxiolytic activity of Salvia elegans.
Urmilesh Jha et al., (2011) evaluated the CNS activity of methanol extract of
Parthenium hysterophorus L. In experimental animals. The present study was carried out
to evaluate the effect of methanol extract of parthenium hysterophorus l (PH) on
psychological behavior of animals. The PH was administered orally in Swiss albino mice
and the CNS effects were evaluated by general behavior, exploratory behavior, and
phenobarbitone sodium induced sleeping time using standard procedures in experimental
animal models.The results revealed that PH at 2.5 and 5 mg/kg caused a significant
reduction in the spontaneous activity (general behavioural profile), exploratory
behavioural pattern (Y maze and head dip test and significantly potentiated
Phenobarbitone sodium–induced sleeping time.The results conclude that the extract
exhibit CNS depressant activity in tested animal models.
AHMAD BILAL et al., (2005) conducted the pharmacological activities on Ethanol
extract of seed of Cassia sophera, Linn. var. purpurea, Roxb. in rats. Eddy's hot plate and
Analgesiometer tests were used to asses antinociceptive activity of Cassia sophera.
Pentobarbitone narcosis potentiation test was used to evaluate hypnotic and sedative
effect, while anticonvulsant activity was evaluated by Maximum electroshock-induced
seizure test and Pentylenetetrazol induced seizure test. Test drug (440 mg/kg) produced
significant analgesia, potentiated the pentobarbitone induced sleeping time and exhibited
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anticonvulsant effect against hind limb tonic extension phase of maximum electroshock
induced seizure test and seizures induced by pentylenetetrazol.
S. V. Joshi et al., (2011) evaluated the aqueous extract of Ocimum sanctum in
experimentally induced Parkinsonism using haloperidol induced catalepsy in rat and
muscle rigidity in mice effects of aq. extract of Ocimum sanctum (OSEaq) were studied.
Haloperidol was administered to induce either short term model (0.5mg/kg i.p) or long
term model (4mg/kg s.c.) to observe changes in catalepsy and muscle rigidity as
measured using rota-rod test and chimney test. Out of 100mg, 200mg, 300mg and
600mg/kg p.o, doses of O. sanctum, 300mg/kg dose showed maximum shortening of
onset and duration of catalepsy as compared with other dose levels in short term and long
term model. Pretreatment with OSEaq (300mg and 450mg/kg p.o.) significantly reduces
initial decrease in activity in rota rod and significantly improves performance of mice in
chimney test as compared with control in short term and long term models. In conclusion,
OSEaq in the dose 300mg/kg i.p. shows anticataleptic action in rats as well as in the dose
300 and 450mg/kg i.p. improves the performance of mice in rota-rod and chimney test
indicating reduction of muscle rigidity. Active constituent-linalool, modulation of central
neurotransmission might be responsible for the antiparkinsonian activity exhibited by
OSEaq.
K. S. Reddy et al., (2012) conducted Psychopharmacological Studies of Hydro
Alcoholic Extract of Whole Plant of Marsilea quadrifolia. The hydro alcoholic extract of
the entire plant Marsilea quadrifolia (HEMQ) was evaluated for different
psychopharmacological actions such as behaviour, exploratory behaviour, muscle
relaxant activity and phenobarbitone induced sleeping time. The extract was found to
cause reduction in spontaneous activity, decrease in exploratory behavioural pattern by
swimming and pole climbing test., reduction in the muscle relaxant by traction test. In
addition, the extract significantly potentiated the phenobarbitone-induced sleeping time.
Preliminary tests indicate that the hydro alcoholic extract of Marsilea quadrifolia in
doses of 200-400 mg/kg has significant psychopharmacological activity.
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De Almeida ER et al.,(2010) investigated the Anxiolytic and anticonvulsant effects of
dioclenol flavonoid isolated from stem bark of dioclea grandiflora on mice. Groups of
mice treated by the intraperitoneal (i.p.) route with doses of 15, 30, and 60 mg/kg (i.p.) of
the fraction and Dioclenol with a dose of 10 mg / kg showed significant action in the
Elevated Plus maze (EPM) (time spent in open arms and time in spent in the closed
arms). The Hole-board Test also showed a significant increase in the time spent in the
Head-dip and Marble-Burying Tests. The same treatment increased the duration of the
sleeping time induced by Sodium Pentobarbital, and showed a significant increase in
protection against Pentylenotetrazole induced convulsion. These results indicate an
anxiolytic-like and anticonvulsant-like effect of the fraction of stem bark of Dg and
Dioclenol in mice. The phytochemical analysis suggests that the alcoholic fraction has
higher concentration of flavonoid active (Dioclenol) and deserves further analysis. The
studies conducted with the Dioclea grandiflora, can contribute, in the long term, in the
field of its action in the CNS this flavonoid
Boadie W. Dunlop, et al.,(2011) has performed an research oriented clinical studies in
human depressed subjects using sophisticated methods like neuroimaging, radioligand
detection etc to determine the role of dopamine in depression.
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3. AIM AND OBJECTIVE
Medicinal plants have been in India for centuries as a therapeutic source for
treating wide variety of ailments and have been found to be of immense global
importance. It is estimated by World Health Organization that, 80% of the world
population must rely on traditional medicines for health care: these traditional medicines
are mainly plant based. Most of the studies demonstrate the importance of natural
products in drug discovery. The use of phytoconstituents as drug therapy to treat major
ailments has proved to be clinically effective and less relatively toxic than the existing
drugs. The selection of plant was made on the basis of its availability, therapeutic value
and degree of research work which is not done.
Depression occurs due to different reasons but majorly the depression occurs due
to brain chemistry imbalance. This is the reason for imbalance of neurotransmitters in
brain. This imbalance in neurotransmitters causes depression. In the CNS system the
depression is due to mainly three types of monoaminogenic neurotransmitters
norepinephrine, serotonin and dopamine. The unavailability of these neurotransmitters
causes depression. Depression is beneficial in diagnosing psychosis, anxiety, sedation
and to produce reduced psychomotor activity etc. Many drugs are available in market
which acts on these neurotransmitters receptors, but clinical evaluation of these drugs has
shown incidence of relapse, side effects, and drug interaction. This has been the rationale
for the development of new drugs and search for novel molecules has been extended to
herbal drugs that offer better activity with less side effects & interaction.
The motive of my present study is to reveal & show the presence of
phytoconstituents in extract of Canavalia maritima that are responsible in producing
depression.
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OBJECTIVES OF THE STUDY
The objectives of the present study are-
 Exploring the traditional medicines with proper chemical and pharmacological
profiles.
 Extraction of Canavalia maritima leaf by different solvents.
 To conduct systematic phytochemical investigation of Canavalia maritima.
 To perform the acute oral toxicological studies.
 To evaluate the antipsychotic activity in rats.
 To evaluate the anxiolytic activity in mice.
 To evaluate the sedative activity in mice.
 To evaluate the spontaneous locomotor activity in mice.
 To evaluate the muscle rigidity activity in mice.
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4. PLAN OF WORK
PHYTOCHEMICAL STUDIES:
1. Collection of plant (Canavalia maritima) leaves and shade dried.
2. Extraction of Canavalia maritima leaf powder using ethanol in soxhlet
apparatus for 72 hrs.
3. Phytochemical investigation of ethanolic extract of Canavalia maritima leaf.
EVALUATION OF ACUTE ORAL TOXICITY STUDIES
PHARMACOLOGICAL STUDIES
1. Evaluation of antipsychotic activity of Canavalia maritima by
 Haloperidol induced catalepsy test.
2. Evaluation of anxiolytic activity of Canavalia maritima by
 Forced swim test.
3.  Evaluation of sedative activity of Canavalia maritima by
 Potentiation of Pentobarbitone sleeping time.
4. Evaluation of muscle relaxant activity of Canavalia maritima by
 Muscle grip strength activity by Rotarod method.
5. Evaluation of spontaneous locomotor activity of Canavalia maritima by
 Locomotion activity by Actophotometer method.
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5. MATERIALS AND METHODS
5.1. PHYTOCHEMICAL STUDIES
5.1.1 EXTRACTION OF PLANT MATERIAL
 Ethanolic extraction:
About 300 gm of air dried powdered material was taken in 1000ml soxhlet
apparatus and extracted with petroleum ether for 18 hours till the solvent became
colourless. At the end of the extraction process the marc was taken out and it was dried.
After drying, the powdered marc was weighed & again packed and extracted with ethanol
for another 72 hours till it became colourless. After that extract was concentrated by
distillation. The final solution was evaporated, to obtain a syrupy greenish mass.
5.1.2. PRELIMINARY PHYTOCHEMICAL ANALYSIS
The plant may be subjected to preliminary Phytochemical screening for detection
of various bioactive chemical constituents. The important steps involved in the
Phytochemical screening of a plant include extraction of constituents using suitable
solvents followed by screening with various chemical tests.
In the process of phytochemical screening, the crude extracts or isolated
constituents are subjected to qualitative and quantitative chemical analysis. Qualitative
chemical analysis includes the determination of nature of the constituents in an extract or
its fractions which lead to the isolation of the active lead compound. Quantitative
Chapter 5 Materials & Methods
Dept of pharmacology 52 J.K.K.Nattraja college of pharmacy
chemical analysis includes the determination of the purity of isolated substances or group
of substances in a mixture by finger printing and different analytical techniques.
Qualitative tests:-
A) Test for carbohydrates;
1. Molisch Test:
It consists of treating the compounds of -naphthol and concentrated sulphuric acid
along the sides of the test tube. Purple colour or reddish violet colour at the junction
between two liquids.
2. Fehling’s Test:
Equal quantity of Fehling’s solution A and B is added. Heat gently, brick red precipitate
is obtained.
3. Benedict’s test:
To the 5ml of Benedict’s reagent, add 8 drops of solution under examination. Mix well,
boiling the mixture vigorously for two minutes and then cool. Red precipitate is obtained.
4. Barfoed’s test:
To the 5ml of the Barfoed’s solution add 0.5ml of solution under examination, heat to
boiling, formation of red precipitate of copper oxide is obtained.
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B) Test for Alkaloids
1. Dragendroff’s Test:
To the extract, add 1ml of Dragendroff’s reagent Orange red precipitate is produced.
2. Wagner’s test:
To the extract add Wagner reagent. Reddish brown precipitate is produced.
3. Mayer’s Test:
To the extract add 1ml or 2ml of Mayer’s reagent. Dull white precipitate is produced.
4. Hager’s Test:
To the extract add 3ml of Hager’s reagent, yellow precipitate is produced.
C) Test for Steroids and Sterols
1. Liebermann Burchard test:
Dissolve the test sample in 2ml of chloroform in a dry test tube. Now add 10 drops of
acetic anhydride and 2 drops of concentrated sulphuric acid. The solution becomes red,
then blue and finally bluish green in colour.
2. Salkowski test:
Dissolve the sample of test solution in chloroform and add equal volume of conc.
sulphuric acid. Bluish red cherry red and purple color is noted in chloroform layer,
whereas acid assumes marked green fluorescence.
D) Test for Glycosides
1. Legal’s test: Sample is dissolved in pyridine; sodium nitroprusside solution is added to
it and made alkaline. Pink red colour is produced.
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2. Baljet test:
To the drug sample, sodium picrate solution is added. Yellow to orange colour is
produced.
3. Borntrager test:
Add a few ml of dilute sulphuric acid to the test solution. Boil, filter and extract the
filtrate with ether or chloroform. Then organic layer is separated to which ammonia is
added, pink, red or violet colour is produced in organic layer.
4. Killer Killani test:
Sample is dissolved in acetic acid containing trace of ferric chloride and transferred to
the surface of concentrated sulphuric acid. At the junction of liquid reddish brown color
is produced which gradually becomes blue.
E) Test for Saponins
Foam test:
About 1ml of alcoholic sample is diluted separately with distilled water to 20ml, and
shaken in graduated cylinder for 15 minutes.1 cm layer of foam indicates the presence of
saponins.
F) Test for Flavonoids
Shinoda test:
To the sample, magnesium turnings and then concentrated hydrochloric acid is added.
Red colour is produced.
Lead acetate test:
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The extracts were treated with few drops of lead acetate solution, formation of yellow
precipitate indicates the presence of flavonoids.
Alkaline reagent test:
The extracts were treated with few drops of sodium hydroxide separately. Formation of
intense yellow color, which becomes colorless on addition of few drops of dilute acid,
indicates the presence of flavonoids
G) Test for Triterpenoid:
In the test tube, 2 or 3 granules of tin was added, and dissolved in a 2ml of thionyl
chloride solution and test solution is added. Pink colour is produced which indicates the
presence of triterpenoids.
H) Test for Protein and Amino acid
1. Biuret test:
Add 1 ml of 40% sodium hydroxide and 2 drops of 1% copper sulphate to the extract, a
violet colour indicates the presence of proteins.
2. Ninhydrin test:
Add 2 drops of freshly prepared 0.2% ninhydrin    reagent to the extract and heat. A blue
colour develops indicating the presence of proteins, peptides or amino acids.
3. Xanthoprotein test:
To the extract, add 20% of sodium hydroxide or ammonia. Orange colour indicates
presence of aromatic amino acid. (Evans W.C 1996, Kandelwal, 2004.)
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5.2 ACUTE ORAL TOXICITY STUDIES
Animals:-
Swiss albino mice of female sex weighing 20-25gms were used for the study. The
animals were were housed in polypropylene cages. The animals were maintained under
standard laboratory conditions (250 + 20C; 12hr light and dark cycle). The animals were
fed with standard diet and water ad libitum. Ethical clearance (for handling of animals
and the procedures used in study) was obtained from the Institutional Animal Ethical
Committee before performing the study on animals.
Acute toxicity Test:
Acute oral toxicity study for methanol extract of Canavalia maritima leaves was
carried out as per OECD guideline 425 (Up and Down procedure). The test procedure
minimizes the number of animals required to estimate the acute oral toxicity. The test
allows the observation of signs of toxicity and can also be used to identify chemicals that
are likely to have low toxicity.
Animals were fasted (food but not water was with held overnight) prior to dosing.
The fasted body weight of each animal was determined and the dose was calculated
according to the body weight.
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5.3 PHARMACOLOGICAL EVALUATION
Animal study:
Male albino-Wistar rats weighing 200-250g, Swiss albino mice weighing 20-25g
were used in the present study.
Housing and feeding condition:
All the rats were kept at room temperature (22±30◦C) in the animal house. All the
animals were housed and treated as per the internationally accepted ethical guidelines for
the care of laboratory animals. Prior to the experiments, rats were fed with standard food
and were acclimatized to standard laboratory conditions of temperature (22±30˚) and
maintained an 12:12 hr light: dark cycle. They were provided with regular rat chow and
distilled water ad libitum. All the experimental procedures were performed on animal
after approval from the ethics committee and in accordance with the recommendations
for the proper care and use of laboratory animals.
Extract:
Ethanolic extract of Canavalia maritima leaf
Standard drug used:
Haloperidol (1mg/kg)
Diazepam (2mg/kg & 5mg/kg)
Pentobarbitone (40mg/kg)
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5.3.1 Evaluation of Antipsychotic activity:
The antipsychotic potential of ethanolic extract of Canavalia maritima leaf was
investigated by Haloperidol induced catalepsy in experimental Wistar rats because
Conditioned avoidance response (CAR) behaviour and catalepsy (CAT) are the standard
preclinical tests used to predict antipsychotic activity and motor side-effect liability
respectively.
HALOPERIDOL INDUCED CATALEPSY TEST:-
Catalepsy is defined as a failure to correct an externally imposed, unusual posture
over a prolonged period of time. Neuroleptics which have an inhibitory action on the
nigrostriatal dopamine system induce catalepsy. This model is used to elucidate the
possible mechanism of action of the ethanolic extract of Canavalia maritima. The
respective standard drug (Haloperidol 1mg/kg) is used for this experimental model.
Experimental Design:
Experimental rats were divided into five groups each groups comprising of six
animals. The treatment group is designated as follows.
Experimental design
Group(n=6) Treatment
Group I Normal Control rats.
Group II Rats treated with C .maritima Ext.(400mg /kg )
Group II Rats treated with C. maritima Ext.(800mg /kg )
Group IV Rats treated with standard drugs
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EXPERIMENTAL PROCEDURE
Male albino-Wistar rats were divided in to four groups as mentioned above of six
animals per group weighing between 200-250g are used.
Group I - normal control (0.5% CMC solution)
Group II - received 400mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group III - received 800mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group IV - received 1 mg/kg, i.p haloperidol as standard.
The test and standard treated animals are measured for catalepsy as follow:-
Scoring for catalepsy:-
The following scoring system was used:
 0 – rat moved normally when placed on the table;
 0.5 – rat moved only when touched or pushed;
 0.5 - rat placed on the table with front paws set alternately on a 3 cm high wooden
block, failed to correct the posture. Time (in sec.) taken to correct the posture (2
min. was considered as cut off time) was multiplied by the score for each paw;
 1.0 - rat failed to correct posture when front paws are placed on a 9 cm high
wooden block, Time (in sec.) taken to correct the posture (2 min. was considered
as cut off time) was multiplied by the score for each paw.
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Formula to calculate catalepsy score: -
Total Score =0.5 + (0.5 x Time in sec. of front right paw on 3 cm high wooden block) +
(0.5 x Time in sec. of front left paw on 3 cm high wooden block) + (1 x Time in sec. of
front right paw on 9 cm high wooden block) + (1 x Time in sec. of front left paw on 9 cm
high wooden block).
For example, rat move only when touched or pushed then score 0.5. Then rat placed on
the table with front right paw set on a 3 cm high wooden block, fails to correct the
posture in specific time (in sec.) say 100 sec. (2 min. was considered as cut off time), the
score 0.5 multiplied by the time taken to correct the posture, the score become 0.5 x 100
= 50. Similarly with left paw, taking time 90sec to correct the posture, score become 0.5
x 90=45. In case of right paw placed on 9 cm high wooden box, taking time of 60 sec to
correct the posture, the score will be 1 x 60 = 60. Similarly with left paw, taking time 80
sec to correct posture, score will be 1 x 80 = 80.
Total score in the above example will be 0.5+50+45+60+80=235.5
Thus, according to the formula, for a single rat, the maximum possible cumulative score
of catalepsy was 360.5. The catalepsy score at the given time interval was plotted against
time and following observations were noted.
1. Onset of overall catalepsy was the time at which animals started showing the
catalepsy.
2. Duration of overall catalepsy was total duration of catalepsy produced.
3. Onset of maximum catalepsy was the time at which animals started to show
maximum score of catalepsy i.e. above 335
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4. Duration of maximum catalepsy was the duration of catalepsy at which the score was
nearer to the maximum score i.e. above 335.
All the rats are measured for their catalepsy score for every 0.5hr, 1hr,
2hr, 3hr and the mean values of each group is calculated.
5.3.2 EVALUATION OF ANXIOLYTIC ACTIVITY:-
The anxiolytic activity of ethanolic extract of Canavalia maritima was
evaluated by Forced swim test.
FORCED SWIM TEST (FST):-
The FST is the most widely used pharmacological in vivo model for
assessing antidepressant activity. The mice were forced to swim in restricted space from
which they cannot escape are induced to a characteristic behavior of immobility. This
behavior reflects a state of depression which can be increased or reduced by test and
standard drug (diazepam 2mg/kg).
Experimental Design:
Experimental rats were divided into five groups each groups comprising of six
animals. The treatment group is designated as follows.
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Experimental design
Group(n=6) Treatment
Group I Normal Control mice.
Group II Mice treated with C. maritima Ext(400mg /kg)
Group III Mice treated with C. maritima Ext(800mg /kg)
Group IV Mice treated with standard drugs
EXPERIMENTAL PROCEDURE
Swiss albino mice were divided in to four groups as mentioned above of six
animals per group weighing between 20-25g are used.
Group I - normal control (0.5% CMC solution)
Group II - received 400mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group III - received 800mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group IV - received 2 mg/kg, i.p diazepam as standard.
The apparatus consisted of a clear plexiglass cylinder (20 cm high×12 cm
diameter) filled to a 15 cm depth with water (24±1 ◦C). When rats are placed in the
cylinders for the first time they are initially highly active, vigorously swimming in
circles, trying to climb the wall or diving to the bottom. After 2–3 min activity begins to
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subside and to be interspersed with phases of immobility or floating of increasing length.
After 5–6 min immobility reaches a plateau where the rats remain immobile for
approximately 80% of the time. After 15 min in the water the rats are removed and
allowed to dry in a heated enclosure (32 °C) before being returned to their home cages.
They are again placed in the cylinder 24 h later and the total duration of immobility is
measured during a 5 min test. Floating behaviour during this 5 min period has been found
to be reproducible in different groups of mice. An animal is judged to be immobile
whenever it remains floating passively in the water in a slightly hunched but upright
position, its nose just above the surface. Test drugs or standard are administered 30 min
prior to testing .It was suggested that the immobility reflected a state of lowered mood in
which the animals had given up hope of finding an exit and had resigned themselves to
the experimental situation.
The immobility of each group is observed before and after the administration
of drugs and their mean values are calculated for every group.
5.3.3 EVALUATION OF SEDATIVE ACTIVITY:-
The sedative & hypnotic activity of ethanolic extract of Canavalia
maritima was evaluated by Potentiation of Phenobarbitone sleeping time.
POTENTIATION OF PENTOBARBITONE SLEEPING TIME:-
The induction or Potentiation of Pentobarbitone sleeping time is the
most widely used in vivo model in assessing the hypnotic & sedative activity. This test is
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used to evaluate CNS active or depression properties of several drugs such as hypnotics,
sedatives, tranquilizers & also antidepressants at high doses. Mice are used in this test
since metabolic elimination of pentobarbital is rapid in this species.
Experimental Design:
Experimental mice were divided into five groups each groups comprising of six
animals. The treatment group is designated as follows.
Experimental design
Group(n=6) Treatment
Group I Normal Control mice.
Group II Mice treated with C. maritima Ext. (400mg /kg )
Group II Mice treated with C. maritima Ext. (800mg /kg )
** All groups receive pentobarbital i.p, (40mg/kg) 30 min after administering the control
& test compounds.
EXPERIMENTAL PROCEDURE
Swiss albino mice were divided in to four groups as mentioned above of six
animals per group weighing 25gs are used.
Group I - normal control (0.5% CMC solution)
Group II - received 400mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group III - received 800mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
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The selected mice are dosed with control, test and standard
compounds as mentioned above. Thirty min later, all the groups were administered with
pentobarbital sodium i.p, (40mg/kg). The animals are placed on their back on warmed
pad or on dry warm cotton. The duration of loss of righting reflex was noted and duration
of sleep was measured as the time interval between loss and regain of righting reflux.
5.3.4 EVALUATION OF MUSCLE RELAXANT ACTIVITY:-
The muscle relaxant activity of ethanolic extract of Canavalia maritima
is evaluated by ROTAROD METHOD.
Rotarod test:-
The test is used to evaluate the activity of drugs interfering with motor
coordination. The skeletal muscle relaxation induced by test compounds can be evaluated
by testing the ability of a mice or rat to remain on revolving rod.
Experimental Design:
Experimental mice were divided into five groups each groups comprising of six
animals. The treatment group is designated as follows.
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Experimental design
Group(n=6) Treatment
Group I Normal Control mice.
Group II Mice treated with C. maritima Ext.  (400mg /kg )
Group III Mice treated with C. maritima Ext. (800mg /kg )
Group IV Mice treated with standard drugs
EXPERIMENTAL PROCEDURE
Swiss albino mice were divided in to four groups as mentioned above of six
animals per group weighing 20-25g are used.
Group I - normal control (0.5% CMC solution)
Group II - received 400mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group III - received 800mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group IV – received 2 mg/kg, i.p diazepam as standard.
The apparatus consists of a horizontal metal rod coated with rubber
with 3cm diameter attached to a motor with a speed adjusted to 5 rotations per minute.
The rod is 75 cm long, divided in to 6 partitions by plastic discs. This helps in testing all
the 6 mice at a time. The rod is 50 cm height above the table top to avoid jumping of
animals from roller. The plates below the roller ceases immediately when animal falls on
them showing the time that animal managed on moving roller.
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The animals of suitable weight are taken and are placed on rod rotating
at 5 rpm. The mice capable of remaining on the top for 3 min or more, in three successive
trails were selected for the study. The control, test & standard groups are dosed as
mentioned above and 30 min later they are again placed on Rotarod for 5 min test. The
number of falling & fall off time from the roller are noted.
5.3.5 EVALUATION OF SPONTANEOUS LOCOMOTOR ACTIVITY:-
The spontaneous locomotor activity of ethanolic extract of Canavalia
maritima is evaluated using the Actophotometer method. The locomotor activity is the
index of wakefulness of mental activity.
Actophotometer method:-
Most of the CNS drugs influence the locomotor activity in animals & man.
The CNS depressants reduce the locomotor activity while stimulants increase the activity.
The locomotor activity can be measured easily by using the Actophotometer method.
The Actophotometer operates on photoelectric cells which are connected in
circuit with a counter. When the beam of light falling on photocell is cut off by the
animal, count is recorded. An Actophotometer could have either circular or square arena
in which the animals moves. The animals are allowed to move freely in the activity cage
before and after administration of drugs. The locomotor activity scores are recorded and
displayed digitally on screen.
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Experimental Design:
Experimental rats were divided into five groups each groups comprising of six
animals. The treatment group is designated as follows:
Experimental design
Group(n=6) Treatment
Group I Normal Control rats.
Group II Rats treated with C. maritima Ext. (400mg /kg )
Group II Rats treated with C .maritima Ext. (800mg /kg )
Group IV Rats treated with standard drugs
EXPERIMENTAL PROCEDURE
Male albino-Wistar rats were divided in to four groups as mentioned above of six
animals per group weighing between 200-250g are used.
Group I - normal control (0.5% CMC solution)
Group II - received 400mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group III - received 800mg/kg, p.o ethanolic extract of Canavalia maritima leaf.
Group IV - received 5 mg/kg, i.p diazepam as standard.
Turn on the equipment and check whether all the photocells are
working for accurate recording. Place invidually each rat in the activity cage for 10 min.
Note the basal activity score of all the animals. The animals were administered orally and
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after 30 mins retest is performed to each rat for activity scores for 10 mins. Note the
difference in the activity before and after administration of plant extracts.
Calculated the percent change
in motor activity by following formula = Before treatment- after treatment × 100
Before treatment
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6. RESULTS AND DISCUSSION
The present study shows that the ethanolic extract of Canavalia maritima leaves
shows Central Nervous System depression activity in experimental animal models. The
present study was done on some disorders that are caused due to CNS depression. They are
 Antipsychotic activity by Haloperidol induced catalepsy test.
 Anxiolytic activity by Forced swim test.
 Sedative & Hypnotic activity by Potentiation of Pentobarbitone sleeping time.
 Muscle relaxant activity by Rotarod method.
 Spontaneous locomotor activity by Actophotometer method.
6.1 PRELIMINARY PHYTOCHEMICAL ANALYSIS
Percentage yield and physical appearance of different extracts
S. No. Extract Colour Yield (%w/w)
1 Pet ether (C. maritima) Greenish Black 4.01
2 Ethanol (C. maritima) Greenish 5.23
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Table showing qualitative chemical tests of leaf extracts of Canavalia maritima:
+ = Present, - = Absent
Phytoconstituents
Extract
Petroleum
ether
Ethanol
Carbohydrates + +
Glycosides - -
Alkaloids - +
Phytosteroids - -
Flavonoids - +
Protein and amino acids - -
Saponins + +
Phenols & tannins - +
Terpenoids - +
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The percentage yield of the extract obtained from the powdered leaves of Canavalia
maritima using successive extraction procedure with solvents of increasing polarity is shown
in Table:7 the percentage yield of extract obtained.
The preliminary Phytochemical screening of the extract of Canavalia maritima
leaves showed the presence of carbohydrates, alkaloids, sterols, flavonoids, saponins, tannins
and phenolic compounds. The various phytoconstituents present in the extract is shown in the
Table 8.
The phytoconstituents like flavonoids, tannins, terpenoids, phenols, tannins,
saponins, alkaloids and sterols have been reported to cause Psychopharmacological actions.
The alkaloids such as canarosine a guanidine alkaloid acts as dopamine inhibitor at D1
receptors. [Rutt Suttisri et al., (oct 2008)].
It is suggested that these compounds will be able to produce Psycopharmacological
changes. They may act on the inhibitory receptors present in the Central Nervous System
Activity such as GABAergic receptors, Dopamine receptors. [C.A. Suresh Kumar et al.,
(Jan 2010)]
Similarly, the ethanol extract of Canavalia mairtima leaf, showed the presence
flavonoids and their alkaloids, phenols and tannins, triterpenoids and saponins. These
phytoconstituents present in the extract could be the possible agents involved in producing
the depression in Central Nervous System. This depression produced may be useful in
treating the Psychosis, Anxiety and also to produce Sedation, Myorelaxant nature & reduced
psychomotor activities. Flavonoids are also capable of scavenging the free radicals. Phenols
and Phenolic compounds have potent antioxidant properties (Berenguer et.al., 2005),
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6.2 PHARMACOLOGICAL STUDIES
6.2.1 ACUTE ORAL TOXICITY STUDIES:-
The acute oral toxicity of the ethanolic extract of Canavalia maritima was carried out as
per OECD 425-guideline. The acute toxicity studies revealed that LD50>2000mg/kg for the
extract.
Acute oral Toxicity study (425) observations.
RESPIRATORY BLOCKAGE IN NOSTRIL
Dyspnoea Nil
Apnoea Nil
Tachypnea Nil
Nostril discharge Nil
MOTOR ACTIVITIES
Locomotion Normal
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Somnolence Nil
Loss of righting reflex Nil
Anaesthesia Nil
Ataxia Nil
Toe walking Nil
Prostration Nil
Fasciculation Nil
Tremor Nil
CONVULSION (INVOLUNTRAY CONTRACTION)
Clonic/tonic/tonic-clonic convulsion Nil
Asphyxial convulsion Nil
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Opistotones (titanic spasm) Nil
REFLEXES
Corneal Normal
Eyelid closure Normal
Righting Normal
Light Normal
Auditory and sensory Normal
OCULAR SIGNS
Lacrimation Nil
Miosis Nil
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Mydriasis Nil
Ptosis Nil
Chromodacryorrhea
Iritis Nil
Conjunctivitis Nil
SALIVATION
Saliva secretion Nil
PILOERECTION
Contraction of erectile tissue Nil
ANALGESIA
Decrease in reaction to induced pain Nil
MUSCLE TONE
Hypo or hypertonia Nil
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GIT SIGN
Solid  dried / watery stool Nil
Emesis Nil
Red urine Nil
SKIN
Oedema Nil
Erythema Nil
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6.2.3. ANTIPSYCHOTIC ACTIVITY:-
HALOPERIDOL INDUCED CATALEPSY TEST
S.No Group Dose Degree of catatonia(score)
0.5hr 1hr 2hr 3hr
1 Control 0.5% CMC 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
2 Test 1 Ext 400mg/kg 189.8±1.4** 157.5±1.5** 133.5±2.8** 119.5±2.3**
3 Test 2 Ext 800mg/kg 343.2±1.4** 337.7±1.7** 317.7±2.0** 293±1.3**
4 Standard 1 mg/kg 359.2±0.61** 357.5±0.77** 333.7±0.83** 314±1.2**
All values are expressed as mean ± S.E.M.; (n=6) animals in each group. **P<0.01.
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6.2.3. ANXIOLYTIC ACTIVITY:-
FORCED SWIM TEST
S.No Group Dose Immobility(sec) % increase in
immobility
Before After
1 Control 0.5% CMC 155±1.3** 165±1.2** 6.45%
2 Test 1 Ext 400mg/kg 140±2.4** 200±1.3** 42.8%
3 Test 2 Ext 800mg/kg 150±1.5** 270±1.6** 80%
4 Standard 2 mg/kg 153±3.0** 280.2±1.8** 83.1%
All values are expressed as mean ± S.E.M.; (n=6) animals in each group. **P<0.01.
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6.2.4. HYPNOTIC & SEDATIVE ACTIVITY:-
POTENTIATION OF PENTOBARBITONE SLEEPING TIME
S.No Group Dose Sleep latency
(min)
Duration of
sleep    (min)
1 Control 0.5% CMC 5.83±0.30** 72±0.73**
2 Test 1 Ext 400mg/kg 4.33±0.21** 90.16±0.65**
3 Test 2 Ext 800mg/kg 3.5±0.22** 122.5±0.71**
All values are expressed as mean ± S.E.M.; (n=6) animals in each group. **P<0.01.
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6.2.5. MUSCLE RELAXANT ACTIVITY:-
ROTAROD METHOD
S.No Group Dose Falling off time (sec) No of fallings
Before After Before After
1 Control 0.5% CMC 200±0.73** 195±0.33** 5.33±0.21** 6±0.16**
2 Test 1 Ext 400mg/kg 190±0.89** 70±0.30** 6±0.00 11±0.21**
3 Test 2 Ext 800mg/kg 200±0.73** 65±0.33** 6±0.00 15±0.25**
4 Standard 2 mg/kg 210±0.36** 52±0.36** 6±0.00 18±0.21**
All values are expressed as mean ± S.E.M.; (n=6) animals in each group. **P<0.01.
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6.2.6. SPONTANEOUS LOCOMOTOR ACTIVITY:-
ACTOPHOTOMETER METHOD
S.No Group Dose Locomotor activity score
(10 min)
% decrease in activity
Before After
1 Control 0.5% CMC 300±1.7** 280±0.85** 6.66%
2 Test 1 Ext 400mg/kg 260±1.46* 170±1.15* 34.61%
3 Test 2 Ext 800mg/kg 268±0.98** 103±1.13* 61.5%
4 Standard 2 mg/kg 300±1.71* 110±0.89** 63.33%
All values are expressed as mean ± S.E.M.; (n=6) animals in each group. **P<0.01, *P<0.1
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Discussion:-
The present study involves the evaluation of Central Nervous System
activity of ethanolic extract of Canavalia maritima on behavioral studies such as Potentiation
of Phenobarbitone Sleeping time, Actophotometer activity test, Rotarod Test, Forced Swim
Test, Haloperidol induced catalepsy test in mice and rats was performed. These screening
models are classic models for evaluating Central Nervous System actions providing
information about Hypnotic & Sedative activity, Spontaneous Locomotor activity or
Psychomotor activity, Myorelaxant activity, Anxiolytic activity and Antipsychotic activity.
The present study showed the effect of ethanolic extracts of Canavalia
maritima on Antipsychotic activity was evaluated by Haloperidol induced catalepsy test in
rat. The catalepsy score is the parameter measured. The results showed that the mean
catalepsy score produced in test1 group (400mg/kg) is 189.8±1.4**, 157.5±1.5**,
133.5±2.8**, 119.5±2.3** showed less catalepsy while test2 group (800mg/kg) produced
significant catalepsy 343.2±1.4**, 337.7±1.7**, 317.7±2.0**, 293±1.3**compared to
standard group (haloperidol 1mg/kg) 359.2±0.61**, 357.5±0.77**, 333.7±0.83**,
314±1.2**at 0.5, 1,2, 3hrs of time. The maximum catalepsy score & catalepsy was observed
for 1 hr after administration of extract in test2 group(800mg/kg). The results show that the
test1, test2 concentrations of ethanolic extract of Canavalia maritima produced a dose
dependent catalepsy in experimental rats.
The Anxiolytic effect of ethanolic extracts of Canavalia maritima on was
evaluated by Forced Swim Test in mice. The immobility period of mice in water is the
parameter measured. The results show that test1 group (400mg/kg) produced less immobility
period while test2 group (800mg/kg) showed a significant immobility time compared to
standard group (diazepam 2 mg/kg). The % increase of immobility time in test1, test2 &
standard groups are 42.8%, 80%, 83.1%. These results suggests that the test1, test2 group (400
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&800 mg/kg) concentrations of ethanolic extract of Canavalia maritima produced a dose
dependent prolongation of immobility period in mice.
The effect of ethanolic extracts of Canavalia maritima on Sedative
activity was evaluated by Potentiation of Pentobarbitone Sleeping time. The sleeping latency
& sleep duration are the parameters evaluated. The results showed that test1 group
(400mg/kg) & test2 group produced sleep latency in 4.33 min and 3.5 min while the control
group produced sleep latency in 5.83 min. Similarly the test1 & test2 concentrations prolonged
the duration of sleep (min) in both the test group mice 90.16±0.65**, 122.5±0.71** than
control group 72±0.73**. This showed that ethanolic extracts of C .maritima produced a dose
dependent sedation in experimental mice.
The effect of ethanolic extracts of Canavalia maritima on Myorelaxant
activity was evaluated by Rotarod method. The falling off time and number of fallings were
the parameters evaluated. There is a decrease in falling off time in test1 group (400mg/kg)
70±0.30**, test2 group (800mg/kg) 65±0.33** & standard group (diazepam 5mg/kg)
52±0.36**, before and after administration of extract and standard compounds. Similarly
there is an increase in number of fallings in test1 group (400mg/kg) 11±0.21**, test2 group
(800mg/kg) 15±0.25** & standard group 18±0.21**, before and after the administration of
extract and standard compounds. These results showed that ethanolic extract of C. maritima
produced a gradual increase in no of falling & gradual decrease in falling off time in
experimental test mice compared to standard while control group showed no significant
variation.
The Psychomotor activity of ethanolic extracts of Canavalia maritima was
studied using the Actophotometer activity cage. The locomotor activity score is taken as
parameter for evaluation. The activity score was reduced in test1 260±1.46* to170±1.15*,
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test2 268±0.98** to 103±1.13* and standard groups 300±1.71* to 110±0.89**. The test1
concentration produced moderate %decrease in activity 34.61% while the test2 produced very
significant %decrease in activity 61.5% when compared to standard group 63.33% in
experimental rats after administering the test & standard group compounds. Thus C. martima
produced a dose dependent decrease in locomotor activity in rats.
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7. SUMMARY AND CONCLUSION
The present study shade dried leaves of Canavalia maritima belonging to
family Fabaceae having medicinally important active constituent is reviewed, with special
emphasis on the biological activities. It has been studied to report on preliminary
Phytochemical and pharmacological activities.
The preliminary Phytochemical screening of the extract of Canavalia
maritima leaves showed the presence of carbohydrates, glycosides, sterols, flavonoids,
saponins, tannins, terpenoids and phenolic compounds. The alkaloids, tannins, terpenoids and
glycosides are present in the extract which may possibly responsible for the
psychopharmacological depression action Canavalia maritima.
For evaluating the Antipsychotic activity haloperidol induced catalepsy was
used. The ethanolic extracts of Canavalia maritima (400mg/kg & 800mg/kg) produced dose
dependent catalepsy in rats compared to standard drug (haloperidol). The inhibition of
dopamine at its receptors is one of the reasons for producing the antipsychotic activity. The
alkaloids such as canarosine a guanidine alkaloid may be responsible for inhibiting the
dopaminergic transmission at its receptors. Along with alkaloids other phytochemical
constituents such as tannins, terpenoids and glycosides present in the extract which may be
possibly responsible for the Antipsychotic action of Canavalia maritima. Further studies to be
done to confirm the antipsychotic activity with varying dose level and with varying chronic &
acute models may suggest the exact mode of action.
The Anxiolytic activity is evaluated by Forced Swim Test. The immobility
period of mice in water is considered in this experiment. The ethanolic extracts of Canavalia
maritima (400mg/kg & 800mg/kg) produced dose dependent prolongation of immobility
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period in test1 & test2 group mice compared to standard group. The present study
demonstrates that ethanolic extracts of C. maritima (400 &800mg/kg) has anxiolytic activity.
This action of C. maritima is functionally similar to benzodiazepines which are widely used
as anxiolytic. The benzodiazepines act through GABA receptors. The mechanism of
anxiolytic activity of C. maritima extract may involve an action in GABAergic transmission;
however further studies are needed to ascertain this.
Earlier reports on the chemical constituents of plants and their pharmacology
suggest that plant containing flavonoids, tannins, saponins possess activity against the CNS
disorders. The phytochemical investigations of C. maritima show that ethanolic extract
contains the flavonoids, tannins, saponins, and terpenoids. It is assured that anxiolytic activity
may be produced due to binding of any of these phytochemical constituents with GABAA-
BZDs complex.
The Sedative activity was studied by Potentiation of Pentobarbitone sleeping
time. The sleep latency and sleep duration are the parameters evaluated. The ethanolic extract
concentrations (400 & 800 mg/kg) produced sleep latency in lesser time in test1 & test2
groups than control group. They also increased the sleep duration in two test group than the
control group. The ethanolic extract of C. maritima produced a dose dependent sedation in
mice suggesting a profile sedative activity. The sedative effect recorded in this study may be
related to an interaction with benzodiazepines and related compounds that bind to receptors
in the CNS and have already been identified in certain plant extracts.
The Myorelaxant activity was performed using the Rotarod method. The
falling off time and no of fallings are given criteria as parameters. The ethanolic extract
concentrations (400 & 800 mg/kg) increased the no of fallings and decreased the falling off
time in rats of both the test groups when compared to standard groups after the administration
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of test & standard compounds. This shows that C. maritima extract produced a significant
dose dependent Myorelaxant activity.
The exploratory behaviour is studied by Spontaneous Locomotor Activity of
rats in Actophotometer activity cage. The ethanolic extract concentrations (400 & 800 mg/kg)
produced reduced exploratory behaviour in both the test groups compared to standard groups.
The test2 concentration 800mg/kg produced a very significant reduction in locomotor activity
than standard. This suggests that ethanolic extract of C. maritima produced reduction in
locomotor activity showing depression activity.
It has been reported that C. maritima contains tannins, alkaloids, flavonoids
triterpenoids & saponins. A number of scientific reports indicated that these phytochemical
constituents produce CNS depressant action. Therefore the presence of these active
constituents in the ethanolic extract of C. maritima may be responsible for the CNS activity.
Since the pharmacological profiles of the present investigation of the ethanolic extract of C.
maritima was similar to that of dopamine it is also possible that they might interact with
dopamine receptor.
However, further investigation is underway to determine the exact phytoconstituents that are
responsible for CNS depressant activity of ethanolic extract of C.maritima and the receptors
involved for the execution of the activity.
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